Effects of individual shock wave therapy vs celecoxib on hip pain caused by femoral head necrosis

BACKGROUND: Celecoxib has been used to treat hip discomfort and functional difficulties associated with osteonecrosis of the femoral head (ONFH), although significant adverse reactions often follow long-term use. Extracorporeal shock wave therapy (ESWT) can delay the progression of ONFH, alleviate t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Jun-Yu, Yan, Jun, Xiao, Jian, Jia, Hai-Guang, Liang, Hao-Jun, Xing, Geng-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Randomized Controlled Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044968/
https://www.ncbi.nlm.nih.gov/pubmed/36998970
http://dx.doi.org/10.12998/wjcc.v11.i9.1974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044968/
https://www.ncbi.nlm.nih.gov/pubmed/36998970
http://dx.doi.org/10.12998/wjcc.v11.i9.1974

Ejemplares similares